Acute flaccid weakness with myelopathy and peripheral nerve involvement in 2 children: Recent characterization of a

Gemma Olive1, Antonia Clarke2, Katja Doerholt3

  • 1Children's Neurosciences, Evelina London Children's Hospital, Kings Health Partners Academic Health Science Centre, UK.

Insights

Acute flaccid weakness in infants can signal central nervous system inflammation or peripheral nerve disease. Early diagnosis requires integrated clinical, imaging, and nerve study assessments for effective management of these overlapping syndromes.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Acute flaccid weakness can be an initial symptom of acute transverse myelitis (ATM), an immune-mediated central nervous system disorder.
  • It may also indicate anterior horn cell syndrome or peripheral nervous system disease.

Observation:

  • Two previously healthy female infants presented with acute flaccid paralysis and encephalopathy.
  • Neuroimaging showed central cord signal abnormalities in both infants.
  • Electrophysiological studies unexpectedly revealed a generalized axonal motor neuropathy.

Findings:

  • The cases highlight overlapping inflammatory syndromes affecting both central and peripheral nervous systems in infants.
  • Combined neuroimaging and electrophysiological findings suggest a complex neurological presentation.

Implications:

  • Integrated clinical, radiological, and neurophysiological assessments are crucial for diagnosing and managing children with these complex neurological conditions.
  • Understanding these overlapping syndromes is vital for timely and appropriate therapeutic interventions in pediatric neurology.
Abstract

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.3K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
7.2K